CDRH Inspectors To Tour Unlucky Irish Facility After Taxus Recall Expands
This article was originally published in The Gray Sheet
Executive Summary
FDA will inspect Boston Scientific's Galway, Ireland stent manufacturing facility to ensure the plant's quality control processes are consistent with those implemented at the firm's Maple Grove, Minn. site